Patient | Age and sex (y) | Duration of Parkinsons’s disease (y) | Hoehn and Yahr stage1-150 | More severe side | UPDRS motor score Off/On | Levodopa taken during study (mg)1-151 | Total daily dose levodopa of (mg)2 | Other medications |
---|---|---|---|---|---|---|---|---|
1 | 57 M | 1 | I | L | 6/1 | 250 | 500 | Pergolide |
2 | 70 M | 4 | II | R | 10/5 | 250 | 500 | None |
3 | 74 M | 5 | II | L | 8/2 | 250 | 500 | None |
4 | 58 M | 12 | II | R | 13/9 | 250 | 1125 | Tolcapone |
5 | 71 F | 14 | III | R | 30/11 | 250 | 750 | None |
6 | 46 M | 15 | III | R | 24/6 | 250 | 750 | Pergolide, Selegiline |
7 | 80 F | 3.5 | III | R | 15/9 | 250 | 625 | None |
8 | 53 F | 6.5 | II | L | 10/5 | 200 | 700 | None |
9 | 64 M | 3 | III | R | 19/12 | 125 | 375 | None |
10 | 51 M | 8.5 | II | L | 13/3 | 375 | 1125 | None |